Prader-Willi Syndrome and Appetite
NCT00175305
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Hyperphagia
Prader-Willi Syndrome
Interventions
DRUG:
Sandostatin LAR
Sponsor
University of British Columbia